Cite
Pitoia F, Marlowe RJ, Abelleira E, et al. Radioiodine thyroid remnant ablation after recombinant human thyrotropin or thyroid hormone withdrawal in patients with high-risk differentiated thyroid cancer. J Thyroid Res. 2012;2012:481568doi: 10.1155/2012/481568.
Pitoia, F., Marlowe, R. J., Abelleira, E., Faure, E. N., Bueno, F., Schwarzstein, D., Lutfi, R. J., & Niepomniszcze, H. (2012). Radioiodine thyroid remnant ablation after recombinant human thyrotropin or thyroid hormone withdrawal in patients with high-risk differentiated thyroid cancer. Journal of thyroid research, 2012481568. https://doi.org/10.1155/2012/481568
Pitoia, Fabián, et al. "Radioiodine thyroid remnant ablation after recombinant human thyrotropin or thyroid hormone withdrawal in patients with high-risk differentiated thyroid cancer." Journal of thyroid research vol. 2012 (2012): 481568. doi: https://doi.org/10.1155/2012/481568
Pitoia F, Marlowe RJ, Abelleira E, Faure EN, Bueno F, Schwarzstein D, Lutfi RJ, Niepomniszcze H. Radioiodine thyroid remnant ablation after recombinant human thyrotropin or thyroid hormone withdrawal in patients with high-risk differentiated thyroid cancer. J Thyroid Res. 2012;2012:481568. doi: 10.1155/2012/481568. Epub 2012 Dec 06. PMID: 23304637; PMCID: PMC3529433.
Copy
Download .nbib
